CLOBAZAM
- Clobazam CLOBAZAM 10 mg/1 Camber Pharmaceuticals, Inc.
- Clobazam CLOBAZAM 10 mg/1 NorthStar RxLLC
- Clobazam CLOBAZAM 10 mg/1 Breckenridge Pharmaceutical, Inc.
- Clobazam CLOBAZAM 10 mg/1 American Health Packaging
- CLOBAZAM CLOBAZAM 10 mg/1 Zydus Pharmaceuticals USA Inc.
- Clobazam CLOBAZAM 10 mg/1 Micro Labs Limited
- Clobazam CLOBAZAM 10 mg/1 Bionpharma Inc.
- CLOBAZAM CLOBAZAM 10 mg/1 Zydus Lifesciences Limited
- Clobazam CLOBAZAM 10 mg/1 Ascend Laboratories, LLC
- Clobazam CLOBAZAM 10 mg/1 Lupin Pharmaceuticals, Inc.
- CLOBAZAM CLOBAZAM 10 mg/1 Accord Healthcare Inc.
- CLOBAZAM CLOBAZAM 10 mg/1 Amneal Pharmaceuticals NY LLC
- Clobazam CLOBAZAM 10 mg/1 Lupin Pharmaceuticals, Inc.
- Clobazam CLOBAZAM 10 mg/1 Sandoz Inc.
- Onfi CLOBAZAM 10 mg/1 Lundbeck Pharmaceuticals LLC
- Clobazam CLOBAZAM 10 mg/1 Breckenridge Pharmaceutical, Inc.
- Clobazam CLOBAZAM 10 mg/1 Upsher-Smith Laboratories, LLC
- Clobazam CLOBAZAM 10 mg/1 Ascend Laboratories, LLC
Summary of product characteristics
Effective Time
20230920
Version
5
Spl Product Data Elements
CLOBAZAM CLOBAZAM CLOBAZAM CLOBAZAM STARCH, CORN LACTOSE MONOHYDRATE MAGNESIUM STEARATE SILICON DIOXIDE TALC OFF-WHITE MODIFIED CAPSULE 13;25 CLOBAZAM CLOBAZAM CLOBAZAM CLOBAZAM STARCH, CORN LACTOSE MONOHYDRATE MAGNESIUM STEARATE SILICON DIOXIDE TALC OFF-WHITE MODIFIED CAPSULE 13;26
Application Number
ANDA211449
Brand Name
CLOBAZAM
Generic Name
CLOBAZAM
Product Ndc
70771-1440
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1440-1 Clobazam Tablets, 10 mg 100 Tablets Rx only Zydus NDC 70771-1441-1 Clobazam Tablets, 20 mg 100 Tablets Rx only Zydus Clobazam tablets- Clobazam Tablets
Spl Medguide
SPL MEDGUIDE
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.